4 Perspectives on Sustainability in Clinical Research
As studies become more complex, stakeholders must be aware of the resources they are utilizing and their impact on the environment.
Sustainability in clinical research is key. As complexity and productivity in the industry continue to rise, so does the need for additional resources. According to a recent IQVIA Institute for Human Data Science report, clinical development productivity rose to its highest level since 2018.
Stakeholders must be keen on how they utilize clinical resources, even with positive trends in productivity and development. With strategic management, industry can ensure the long-term effectiveness of clinical trials and their ability to bring therapies to patients faster.
In this slideshow, Julia Sundari, senior director of clinical design and analytics, IQVIA; Michael Cohen, MSc, MBA, senior director, lead, environmental sustainability, PPD clinical research business of Thermo Fisher Scientific; Robyn Owens, manager, recruitment and engagement, PPD clinical research business of Thermo Fisher Scientific; Bill Sterling, senior director of environmental, health and safety, IQVIA Laboratories; and Bryan Spielman, chief growth officer, Advarra each share a critical component to ensuring the long-term effectiveness of clinical research.
Image Credit: © Dee karen - stock.adobe.com
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
What Can ClinOps Learn from Pre-Clinical?
August 10th 2021Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
